These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 36110863

  • 1. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y.
    Front Immunol; 2022; 13():987841. PubMed ID: 36110863
    [Abstract] [Full Text] [Related]

  • 2. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013 Feb 12; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations and outcome of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody positive patients with interstitial lung disease.
    Feng L, Wang H, Zhao Y, Zhao T, Zhang J, Huang F, Zhu J.
    Clin Exp Rheumatol; 2022 Jan 12; 40(1):97-103. PubMed ID: 33635220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies.
    Chen F, Li S, Wang T, Shi J, Wang G.
    Am J Med Sci; 2018 Jan 12; 355(1):48-53. PubMed ID: 29289262
    [Abstract] [Full Text] [Related]

  • 10. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
    Lan JL, Chang SH, Tsay GJ, Chen DY, Chao YH, Li JP.
    BMC Immunol; 2023 Sep 26; 24(1):33. PubMed ID: 37752437
    [Abstract] [Full Text] [Related]

  • 11. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 26; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 12. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
    Abe T, Tsunoda S, Nishioka A, Azuma K, Tsuboi K, Ogita C, Yokoyama Y, Furukawa T, Maruoka M, Tamura M, Yoshikawa T, Saito A, Sekiguchi M, Azuma N, Kitano M, Matsui K, Hosono Y, Nakashima R, Ohmura K, Mimori T, Sano H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Jun 26; 39(2):140-4. PubMed ID: 27212600
    [Abstract] [Full Text] [Related]

  • 13. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan 26; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H.
    Respir Med; 2017 Nov 26; 132():189-194. PubMed ID: 29229096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.
    PLoS One; 2015 Nov 26; 10(3):e0120313. PubMed ID: 25789468
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
    Nakashima R, Hosono Y, Mimori T.
    Lupus; 2016 Jul 26; 25(8):925-33. PubMed ID: 27252271
    [Abstract] [Full Text] [Related]

  • 18. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M, Dong X, Zheng Y.
    Medicine (Baltimore); 2021 May 14; 100(19):e25816. PubMed ID: 34106621
    [Abstract] [Full Text] [Related]

  • 20. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
    Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, Chen Z, Ye S.
    Clin Rev Allergy Immunol; 2021 Apr 14; 60(2):293-304. PubMed ID: 33405101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.